findmyKOL
Clinical trialNCT03964480RecruitingObservational

Prospective Observational International Registry of Patients With Newly Diagnosed Peripheral T Cell Lymphoma.

SponsorAssociazione Angela Serra per la ricerca sul cancroEnrollment1,000Peripheral T-Cell Lymphoma
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study T-Cell Project 2.0 is based on the former International PTCL study designed by the International T-cell Non-Hodgkin's Lymphoma Study Group (T-Cell Project 1.0: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma) as a prospective collection of data to predict the prognosis of patients with the more frequent subtypes of PTCL. It is a prospective, longitudinal, international, observational study of patients with newly diagnosed peripheral T-cell lymphoma aiming to verify whether this prospective collection of data would allow achieving a more accurate information on T-cell lymphomas. The study aims to better define the clinical relevance of the new WHO Classification, the role of FDG-PET in staging and response assessment, the prognosis of different entities, the genomic landscape of different subtypes, and to investigate on most optimal treatment strategies for these neoplasms in the real-world population as well as molecular markers and to explore the prognostic or predictive implications of them in PTCL. The study aims to better define the clinical relevance of the new WHO Classification, the role of FDG-PET in staging and response assessment, the prognosis of different entities, the genomic landscape of different subtypes, and to investigate on most optimal treatment strategies for these neoplasms in the real-world population.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Italy
  • Irccs Istituto Tumori "giovanni Paolo Ii"

    Bari, Italy

    Recruiting
  • Palermo_la Maddalena

    Palermo, Italy

    Not, yet, recruiting
  • Terni-Santa Maria

    Terni, Italy

    Not, yet, recruiting
Romania
  • Cluj Napoca_ion Chiricuta Oncology Institute

    Cluj-Napoca, Romania

    Recruiting
Ukraine
  • National Cancer Institute

    Kiev, Ukraine

    Recruiting
United States
  • Stanford University

    Stanford, California, United States

    Not, yet, recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
14 Oct 2018
Primary completion
30 Jul 2025
Completion
30 Jul 2025
Last update posted
6 May 2025
Registered enrollment
1,000
Registry id
NCT03964480

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.